- Home
- SCLX vs HQI Comparison
SCLX vs HQI Comparison
Compare SCLX & HQI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCLX
- HQI
- Stock Information
- Founded
- SCLX 2011
- HQI 2002
- Country
- SCLX United States
- HQI United States
- Employees
- SCLX N/A
- HQI N/A
- Industry
- SCLX Biotechnology: Pharmaceutical Preparations
- HQI Professional Services
- Sector
- SCLX Health Care
- HQI Consumer Discretionary
- Exchange
- SCLX Nasdaq
- HQI Nasdaq
- Market Cap
- SCLX 139.3M
- HQI 140.2M
- IPO Year
- SCLX N/A
- HQI N/A
- Fundamental
- Price
- SCLX $15.30
- HQI $8.93
- Analyst Decision
- SCLX Hold
- HQI Buy
- Analyst Count
- SCLX 1
- HQI 1
- Target Price
- SCLX N/A
- HQI $13.00
- AVG Volume (30 Days)
- SCLX 140.1K
- HQI 13.0K
- Earning Date
- SCLX 08-13-2025
- HQI 11-06-2025
- Dividend Yield
- SCLX N/A
- HQI 2.72%
- EPS Growth
- SCLX N/A
- HQI 412.84
- EPS
- SCLX N/A
- HQI 0.50
- Revenue
- SCLX $40,360,000.00
- HQI $31,691,000.00
- Revenue This Year
- SCLX $89.26
- HQI N/A
- Revenue Next Year
- SCLX $203.95
- HQI $1.38
- P/E Ratio
- SCLX N/A
- HQI $17.69
- Revenue Growth
- SCLX N/A
- HQI N/A
- 52 Week Low
- SCLX $3.60
- HQI $7.75
- 52 Week High
- SCLX $34.27
- HQI $15.75
- Technical
- Relative Strength Index (RSI)
- SCLX 42.42
- HQI 51.06
- Support Level
- SCLX $17.28
- HQI $9.15
- Resistance Level
- SCLX $19.56
- HQI $10.00
- Average True Range (ATR)
- SCLX 1.97
- HQI 0.48
- MACD
- SCLX -0.02
- HQI 0.11
- Stochastic Oscillator
- SCLX 3.68
- HQI 62.22
About SCLX Scilex Holding Company
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.
About HQI HireQuest Inc. (DE)
HireQuest Inc is a nationwide franchisor of offices providing direct-dispatch, executive search, and commercial staffing solutions in the light industrial and blue-collar segments of the staffing industry and traditional commercial staffing. The company's franchisees provide various types of temporary personnel through two business models operating under the trade names HireQuest Direct, HireQuest, Snelling, DriverQuest, HireQuest Health, Northbound Executive Search, and MRI. The company's primary source of revenue is royalty fees based on the operation of its franchised offices.